Hypercholesterolemia
Conditions
Interventions
This is a quasi-experimental intervention study, with a single group, which will be evaluated before the intervention, during (30 days after the start) and after the intervention. Will be included nur
Sponsors
Universidade Federal de Santa Maria
Universidade Federal de Santa Maria
Eligibility
Age
30 Years to No maximum
Inclusion criteria
Inclusion criteria: Nursing assistants; nursing technicians; nurses; work in emergency services (emergency care unit and hospital emergency department) for at least one month; aged 30 years or older; under any form of contract
Exclusion criteria
Exclusion criteria: Hypersensitivity to Rosemary; pregnant women; lactating women; epileptics; dyslipidemia treatment; diabetes mellitus treatment; biliary or hepatic dysfunction; prostatic diseases; gastroenteritis; those with hair < 2 cm in the region of the posterior vortex of the head; use of topical medication on the scalp; or away from work for any reason during the data collection period
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected to observe an improvement in the quality of sleep, evaluated by the application of the Pittsburgh Sleep Quality Index, with an increase of at least 1.5 points in the general average of sleep quality. Data collected one week before and one week after the intervention;It is expected to observe an improvement in the scores of anxiety, depression and stress, evaluated in the Anxiety, Depression and Stress Scale (EADS-21), with a reduction of at least 3.5 points in the general average of each score. Data collected one week before and one week after the intervention;It is expected to observe an improvement in the Framingham Global Risk Score (ERG-Framingham), evaluated by the application of the ERG-Framingham, with a reduction of at least 1.4%. Data collected one week before and one week after the intervention | — |
Secondary
| Measure | Time frame |
|---|---|
| A 15% reduction in fasting blood glucose levels is expected to be observed through laboratory tests performed one week pre- and post-intervention, and 20 days after the start of the intervention;A 20% reduction in low-density lipoprotein cholesterol levels is expected to be observed as assessed by laboratory tests performed one week pre- and post-intervention ;It is expected to observe a 20% reduction in triglyceride levels assessed through laboratory tests performed one week pre and post-intervention, and 20 days after the start of the intervention | — |
Countries
Brazil
Contacts
Public ContactCarolina Pretto
Universidade Federal de Santa Maria
Outcome results
None listed